Cerezyme (imiglucerase for injection)
FDA INDICATION: Pediatric and adult patients with a confirmed diagnosis of Type 1 Gaucher disease that results in at least one of these conditions: anemia, thrombocytopenia, bone disease, hepatomegaly, and splenomegaly. Package Insert
DISTRIBUTOR: Sanofi Genzyme
ROUTE OF ADMINISTRATION: Intravenous
DOSAGE AND ADMINISTRATION: 2.5 U/kg of body weight 3 times a week to 60 U/kg once every two weeks.
HOW SUPPLIED: 200 units per vial and 400 units per vial.
DILUENT: 0.9% sodium chloride injection
MAX INFUSION RATE: 1 unit/kg/minute
STORAGE REQUIREMENTS: Refrigerate vials at 2–8°C (36–46°F).
OTHER WEBSITES: cerezyme.com, CareConnectPSS.com, GaucherCare.com